Team

Ph.D., Medicine. Author of more than 30 publications and Russian and Eurasian Patents in Molecular Diagnostics. Doctor of clinical and laboratory diagnostics, Public health professional. Graduate of Presidential Program for Management Training. Specialty «Medicine management». Seven years of innovative companies’ management at molecular genetics sphere. Successful participation at Start programs of the Development Assistance Fund. Experience in production of genetic test-systems from scratch, obtaining of Registration Certificates for products in Russia, Kazakhstan and Belarus, CE mark in Europe. Experience in implementation of quality management system, ISO 9001 and ISO 13485 certification.

Ph.D., Biology. Head of Laboratory for Molecular Genetics of Russian Federal Scientific and Clinical Center (FSCC), molecular geneticist, developer of the test-systems for molecular diagnostics, author of more than 100 publications in molecular genetics. Specialist in bioinformatics and development of kits for molecular genetic testing. He developed and applied into the scientific practice a lot of methods of genotyping and mutations detection in hereditary and oncological diseases, has wide experience in implementation of NGS solutions into clinical practice, took part in market
launch of some medical products (kits for noninvasive fetal RHD and SRY gene detection, kits for detection of oncogene mutations etc.). Author of Eurasian and Russian Patents in molecular diagnostics.

The sale and market launch of innovative kits for molecular genetics testing. Increases sale by 3,8 times for 1 year.

Ph.D., Biology. Author of more than 100 research articles, participant of 11 grants. Passed the trainings on molecular and biology methods of researches, including automated synthesis of DNA/RNA, DNA cloning, phage display technology, etc. Developer of the test-system for prostate cancer diagnostics (determination of PCA3 gene expression, chimeric genes, DNA methylation level), test-systems for detection of genetic predisposition to diabetic rethynopathy, diagnostic of hypergenetic teratosis of adrenal cortex (21-hydroxylase deficiency), person identification (by SNP-typing), genes mutations responsible for the effectiveness of targeted therapy in oncology (detection of polymorphisms by real-time PCR), non-invasive tests for prenatal diagnostics (aneuploidy), kits for DNA isolation and purification from different biological sources (blood, plasma, tissue, plants).